Outlook Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
GRIFFITH DONALD J. director
 Common Stock 1 N/A N/A
Sale
GANGLOFF SCOTT A. officer: SVP, Development & Mfrg
 Common Stock 37,369 N/A N/A
Sale
MCANDREW STEPHEN J officer: SVP Bus. Strat. & Dev.
 Common Stock 21,367 N/A N/A
Option
GANGLOFF SCOTT A. officer: SVP, Development & Mfrg
 Common Stock 115,942 N/A N/A
Option
MCANDREW STEPHEN J officer: SVP Bus. Strat. & Dev.
 Common Stock 57,971 N/A N/A
Option
CANUTE SCOTT A director
 Common Stock 57,971 N/A N/A
Option
BRADY TODD C director
 Common Stock 28,985 N/A N/A
Option
GRIFFITH DONALD J. director
 Common Stock 144,927 N/A N/A
Purchase
BAHRT KENNETH officer: Chief Medical Officer
 Series A Warrants (right to buy) 1,000 N/A N/A
Purchase
BAHRT KENNETH officer: Chief Medical Officer
 Common Stock 2,000 N/A N/A

Showing 100 to 110 of 110 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: